Molecular Identification and Antifungal Susceptibility Patterns of Candida Species Isolated from Candidemia Patients in Yasuj, Southwestern Iran
Open Access
- 28 August 2021
- journal article
- research article
- Published by Briefland in Jundishapur Journal of Microbiology
- Vol. 14 (7)
- https://doi.org/10.5812/jjm.117643
Abstract
Background: Candidemia is the most common systemic infection in hospitalized patients causing high mortality. Hence, the diagnosis of this infection in the early stage with appropriate antifungal therapy is paramount. Objectives: The study aimed at molecular identification of Candida species isolated from candidemia patients and evaluation of the in vitro antifungal susceptibility patterns of these strains to fluconazole, amphotericin B, and caspofungin. Methods: In the present study, 800 hospitalized patients who were suspected to have candidemia were sampled. Candida species were isolated and identified based on morphological characteristics and PCR-sequencing of the ITS1-5.8S-ITS2 region. Antifungal susceptibility tests for fluconazole, amphotericin B, and caspofungin were performed according to the Clinical and Laboratory Standards Institute protocol M27-A3. Also, clinical data were recorded from the patients' records. Results: Twenty-seven patients among the sample of hospitalized patients were found to have candidemia. A total of 33.3% of candidemia patients were treated with amphotericin B, in which case the mortality rate was 14.8%. The majority of patients (59%) were from the neonatal intensive care unit, and premature birth was the most common underlying condition. Candida albicans (n = 18; 66.6%) was the most common species isolated from blood cultures, followed by C. parapsilosis (n = 7; 25.9%), C. pelliculosa (n = 1; 3.7%), and C. tropicalis (n = 1; 3.7%). Only one C. albicans isolate resistant to fluconazole (minimum inhibitory concentration = 32 µg/mL). Conclusions: Generally, C. albicans has been the most frequent causative agent of candidemia. Resistance to antifungal drugs among candidemia agents was rare. Also, the identification of Candida isolates at the species level with in vitro antifungal susceptibility tests helps manage candidemia patients better and decrease the mortality rate among them.Keywords
This publication has 38 references indexed in Scilit:
- In Vitro Susceptibility ofCandidaSpecies to Four Antifungal Agents Assessed by the Reference Broth Microdilution MethodThe Scientific World Journal, 2013
- Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in ChinaBMC Infectious Diseases, 2013
- In vitro antifungal susceptibilities of Candida isolates from patients with invasive candidiasis in Kuala Lumpur Hospital, MalaysiaJournal of Medical Microbiology, 2011
- Candidemia epidemiology and susceptibility profile in the largest Brazilian teaching hospital complexThe Brazilian Journal of Infectious Diseases, 2010
- Species identification and strain differentiation of clinical Candida isolates using the DiversiLab system of automated repetitive sequence-based PCRJournal of Medical Microbiology, 2007
- Prospective Observational Study of Candidemia in São Paulo, Brazil: Incidence Rate, Epidemiology, and Predictors of MortalityInfection Control & Hospital Epidemiology, 2007
- Molecular subtyping of clinical isolates of Candida albicans and identification of Candida dubliniensisin MalaysiaMycopathologia, 2005
- Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance StudyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- A Prospective Observational Study of Candidemia: Epidemiology, Therapy, and Influences on Mortality in Hospitalized Adult and Pediatric PatientsClinical Infectious Diseases, 2003
- Epidemiology, treatment and outcome of candidemia: a five‐year review at three Canadian hospitalsMycoses, 2002